Home › NDC Lookup › RxCUI directory › RxCUI 1659927

Sonidegib 200 MG Oral Capsule [Odomzo] — RxCUI 1659927

RxNorm drug concept · Semantic branded drug
RxCUI 1659927 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1659927
Official nameSonidegib 200 MG Oral Capsule [Odomzo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOdomzo 200 MG (as sonidegib phosphate) Oral Capsule; Odomzo 200 MG Oral Capsule
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)147 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sonidegib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Odomzo is used to treat a specific type of skin cancer called locally advanced basal cell carcinoma — basically, a basal cell skin cancer that's grown too far for surgery or radiat...
  • Yes, it matters a lot. You need to take Odomzo on an empty stomach — at least 1 hour before eating or 2 hours after a meal. Eating a high-fat meal with it can increase how much dru...
  • Does it matter when I take my capsule — like, with food or without?
  • Muscle spasms, hair loss, taste changes, fatigue, nausea, and muscle aching are very common — more than half of people on Odomzo experience some muscle symptoms. These are annoying...
📖 Read our full Sonidegib guide →

🕸️ Concept Web — How Sonidegib 200 MG Oral Capsule [Odomzo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sonidegib 200 MG Oral Capsule [Odomzo] RxCUI 1659927

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sonidegib 1659191
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Odomzo 1659922
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sonidegib Oral Capsule 1659920
    • Sonidegib Oral Product 1659918
    • Sonidegib Pill 1659919
    • Sonidegib Oral Capsule [Odomzo] 1659924
    • Odomzo Oral Product 1659925
    • Odomzo Pill 1659926
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sonidegib 200 MG Oral Capsule SCD · 1659921
  • Sonidegib 200 MG SCDC · 1659917
  • Sonidegib Oral Capsule SCDF · 1659920
  • Sonidegib Oral Product SCDG · 1659918
  • Sonidegib Pill SCDG · 1659919

Brand-Name Concepts

  • Sonidegib 200 MG [Odomzo] SBDC · 1659923
  • Sonidegib Oral Capsule [Odomzo] SBDF · 1659924
  • Odomzo Oral Product SBDG · 1659925
  • Odomzo Pill SBDG · 1659926
  • Odomzo BN · 1659922

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1659927 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
47335-0303-15 30 CAPSULE in 1 BOTTLE (47335-303-15) Odomzo Sun Pharmaceutical Industries, Inc. 2017-09-21
47335-0303-83 30 CAPSULE in 1 BOTTLE (47335-303-83) Odomzo Sun Pharmaceutical Industries, Inc. 2017-09-21
Observed labelers: Sun Pharmaceutical Industries, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.